J. Stark Thompson PhD - 09 Aug 2021 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Reporting relationship: Director
Issuer ticker: MXCT
Reported as of: 09 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2021, 17:19:50 UTC
Prior SEC filing: 29 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Katie A. Kazem, attorney-in-fact

Key filing fact

J. Stark Thompson PhD filed Form 4 for MAXCYTE, INC. (MXCT) on 11 Aug 2021.

Key facts

This page summarizes J. Stark Thompson PhD's Form 4 filing for MAXCYTE, INC. (MXCT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Aug 2021, 17:19.

Change

Previous filing in this sequence was filed on 29 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MXCT transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 09 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $16.63
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date.